Norma Rogers

Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitors.

Jennifer E. Golden, R. Bürli, V. Viswanadhan, 2008, Bioorganic & medicinal chemistry letters.

Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation.

R. Bürli, V. Viswanadhan, R. Hungate, 2008, Bioorganic & medicinal chemistry letters.

Control of rHuEPO biological activity: the role of carbohydrate.

S. Elliott, J. Egrie, J. Browne, 2004, Experimental hematology.

Enhancement of therapeutic protein in vivo activities through glycoengineering

L. Buck, K. Aoki, T. Osslund, 2003, Nature Biotechnology.

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor

P. Maxwell, S. Kiriakidis, C. Schofield, 2017, Kidney international.

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor

P. Maxwell, S. Kiriakidis, C. Schofield, 2017, Kidney international.

Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells

S. Powers, K. Nguyen, S. Elliott, 2008, British Journal of Cancer.